REGULATORY
PAFSC’s Second Committee on Drugs to Review Kyowa Kirin’s ATL Treatment on February 1
The Ministry of Health, Labor and Welfare (MHLW; Korosho) will hold a meeting of its Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) Second Committee on Drugs on February 1 and review a new drug application for Kyowa Hakko Kirin’s mogamulizumab…
To read the full story
REGULATORY
- Update: DMD Gene Therapy Elevidys Cleared for NHI Listing at 305 Million Yen
February 13, 2026
- MHLW Orders Label Revisions for Vyxeos, Inlyta, Imbruvica, and More Drugs
February 13, 2026
- MHLW Orders Label Revisions for Sulfite-Containing Medical Products
February 13, 2026
- PMDA Urges Proper Use of Colchicine, Advises against High-Dose Administration
February 12, 2026
- PMDA to Offer Priority Consultations for Overseas Startups
February 12, 2026
The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…





